阿奇霉素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "阿奇霉素" in Chinese language version.

refsWebsite

Global rank Chinese rank

30doi.org

2^nd place

23^rd place

30nih.gov

4^th place

5^th place

25web.archive.org

1^st place

7semanticscholar.org

11^th place

332^nd place

4drugs.com

399^th place

208^th place

2deutschemedz.de

low place

2books.google.com

3^rd place

8^th place

2handle.net

102^nd place

492^nd place

2worldcat.org

5^th place

12^th place

2cdc.gov

218^th place

198^th place

2clincalc.com

3,912^th place

5,917^th place

2canada.ca

1,712^th place

3,316^th place

1tga.gov.au

3,984^th place

1,603^rd place

1medicines.org.uk

3,823^rd place

3,456^th place

1europa.eu

68^th place

209^th place

1msh.org

low place

2,351^st place

1medicaid.gov

low place

1sciencedirect.com

149^th place

292^nd place

1chestnet.org

low place

1nytimes.com

7^th place

31^st place

1fda.gov

447^th place

581^st place

1hanstenandhorn.com

low place

1sdu.dk

9,605^th place

low place

1researchgate.net

120^th place

337^th place

1fkit.hr

low place

1wipo.int

1,462^nd place

2,636^th place

1harvard.edu

18^th place

57^th place

1nihr.ac.uk

low place

books.google.com

Greenwood D. Antimicrobial drugs : chronicle of a twentieth century medical triumph 1st. Oxford: Oxford University Press. 2008: 239. ISBN 978-0-19-953484-5. （原始内容存档于2016-03-05）.
Alapi EM, Fischer J. Table of Selected Analogue Classes. Fischer J, Ganellin CR (编). Analogue-based Drug Discovery. Weinheim: Wiley-Vch Verlag GmbH & Co. KGaA. 2006: 498 [2020-04-02]. ISBN 978-3-527-31257-3. （原始内容存档于2023-01-14）.

canada.ca

health-products.canada.ca

Zithromax Product information. Health Canada. 2013-01-16 [2024-04-26].

canada.ca

Drug and medical device highlights 2018: Helping you maintain and improve your health. Health Canada. 2020-10-14 [2024-04-17].

cdc.gov

Outpatient Antibiotic Prescriptions — United States, 2017 (PDF). U.S. Centers for Disease Control and Prevention (CDC). 2020-03-26 [2020-03-30]. （原始内容存档于2020-03-30）.
Outpatient Antibiotic Prescriptions — United States, 2022. U.S. Centers for Disease Control and Prevention (CDC). 2023-11-15 [2023-11-17]. （原始内容存档于2024-03-08）.

chestnet.org

journal.chestnet.org

Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. February 2004, 125 (2 Suppl): 52S–60S; quiz 60S–61S [2020-03-22]. PMID 14872001. doi:10.1378/chest.125.2_suppl.52S. （原始内容存档于2021-08-27）.

clincalc.com

The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
Azithromycin Drug Usage Statistics, United States, 2013 - 2022. ClinCalc. [2024-08-30].

deutschemedz.de

Azithromycin Stops The Growth of Bacteria. [2017-12-24]. （原始内容存档于2020-05-12）（德语）.
Azithromycin Stops The Growth of Bacteria. [2017-12-24]. （原始内容存档于2020-05-12）（德语）.

doi.org

Dunker A, Kolanczyk DM, Maendel CM, Patel AR, Pettit NN. Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center. Hosp Pharm. November 2016, 51 (10): 830–833. PMC 5135431 . PMID 27928188. doi:10.1310/hpj5110-830.
Klapan I, Culig J, Oresković K, Matrapazovski M, Radosević S. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology. 1999, 20 (1): 7–11 [2024-05-31]. PMID 9950107. doi:10.1016/S0196-0709(99)90044-3. In adults with acute sinusitis, a 3-day course of azithromycin was as effective and well tolerated as a 10-day course of amoxicillin/clavulanic acid. A significantly simpler dosage regimen and faster clinical effect were the advantages of azithromycin.
Dawit G, Mequanent S, Makonnen E. Efficacy and safety of azithromycin and amoxicillin/clavulanate for otitis media in children: a systematic review and meta-analysis of randomized controlled trials. Annals of Clinical Microbiology and Antimicrobials. 2021, 20 (1): 28. PMC 8070272 . PMID 33894769. doi:10.1186/s12941-021-00434-x . Azithromycin is comparable to amoxicillin/clavulanate to treat otitis media in children, and it is safer and more tolerable.
Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. The Cochrane Database of Systematic Reviews. November 2015, 11 (11): CD004008. PMC 4661324 . PMID 26568232. doi:10.1002/14651858.CD004008.pub3.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases //www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997 |PMC=缺少标题 (帮助). March 2007, 44 (Suppl 2): S27–72. PMC 7107997 . PMID 17278083. doi:10.1086/511159 .
Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. The Cochrane Database of Systematic Reviews. November 2015, 11 (11): CD004008. PMC 4661324 . PMID 26568232. doi:10.1002/14651858.CD004008.pub3.
Taylor SP, Sellers E, Taylor BT. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly. The American Journal of Medicine. December 2015, 128 (12): 1362.e1–6. PMID 26291905. doi:10.1016/j.amjmed.2015.07.032 .
Sybilski AJ. Azithromycin – more than an antibiotic. Pediatria I Medycyna Rodzinna. 2020, 16 (3): 261–267. doi:10.15557/PiMR.2020.0048 .
Opitz DL, Harthan JS. Review of Azithromycin Ophthalmic 1% Solution (AzaSite) for the Treatment of Ocular Infections. Ophthalmol Eye Dis. 2012, 4: 1–14. PMC 3619494 . PMID 23650453. doi:10.4137/OED.S7791.
Simoens S, Laekeman G, Decramer M. Preventing COPD exacerbations with macrolides: a review and budget impact analysis. Respiratory Medicine. May 2013, 107 (5): 637–48. PMID 23352223. doi:10.1016/j.rmed.2012.12.019 .
Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. February 2004, 125 (2 Suppl): 52S–60S; quiz 60S–61S [2020-03-22]. PMID 14872001. doi:10.1378/chest.125.2_suppl.52S. （原始内容存档于2021-08-27）.
Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. European Journal of Clinical Pharmacology. May 2012, 68 (5): 479–503. PMID 22105373. S2CID 1904304. doi:10.1007/s00228-011-1161-x .
Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators of Inflammation //www.ncbi.nlm.nih.gov/pmc/articles/PMC3388425 |PMC=缺少标题 (帮助). 2012, 2012: 584262. PMC 3388425 . PMID 22778497. doi:10.1155/2012/584262 .
Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M, Novembre E. Azithromycin anaphylaxis in children. International Journal of Immunopathology and Pharmacology. 2014, 27 (1): 121–6. PMID 24674687. S2CID 45729751. doi:10.1177/039463201402700116 .
Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. The New England Journal of Medicine. May 2012, 366 (20): 1881–90. PMC 3374857 . PMID 22591294. doi:10.1056/NEJMoa1003833.
Tan MS, Gomez-Lumbreras A, Villa-Zapata L, Malone DC. Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure. Rheumatol Int. December 2022, 42 (12): 2253–2259. PMC 9473467 . PMID 36104598. doi:10.1007/s00296-022-05201-5.
Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review (PDF). Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317 [2024-02-02]. PMID 31628882. doi:10.1111/bcpt.13343. （原始内容存档 (PDF)于2024-02-02）.
Bekele LK, Gebeyehu GG. Application of Different Analytical Techniques and Microbiological Assays for the Analysis of Macrolide Antibiotics from Pharmaceutical Dosage Forms and Biological Matrices. ISRN Analytical Chemistry. 2012, 2012: 1–17. doi:10.5402/2012/859473 .
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. Postgrad Med. 2017-06, 129 (5): 493–499 [2024-10-04]. doi:10.1080/00325481.2017.1285677. （原始内容存档于2024-10-07）（英语）.
Hicks LA, Taylor TH, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010. The New England Journal of Medicine. April 2013, 368 (15): 1461–2. PMID 23574140. doi:10.1056/NEJMc1212055 .
Hicks LA, Taylor TH, Hunkler RJ. More on U.S. outpatient antibiotic prescribing, 2010. The New England Journal of Medicine. September 2013, 369 (12): 1175–6. PMID 24047077. doi:10.1056/NEJMc1306863.
Durán-Álvarez JC, Prado B, Zanella R, Rodríguez M, Díaz S. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment. Sci Total Environ. November 2023, 900: 165886. Bibcode:2023ScTEn.90065886D. PMID 37524191. S2CID 260323001. doi:10.1016/j.scitotenv.2023.165886.
Southern KW, Barker PM. Azithromycin for cystic fibrosis. Eur Respir J. November 2004, 24 (5): 834–8. PMID 15516680. S2CID 17778741. doi:10.1183/09031936.04.00084304 .
Azithromycin and cystic fibrosis. Arch Dis Child. August 2022, 107 (8): 739. PMID 35853636. S2CID 250624603. doi:10.1136/archdischild-2022-324569.
Ghimire JJ, Jat KR, Sankar J, Lodha R, Iyer VK, Gautam H, Sood S, Kabra SK. Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial. Chest. June 2022, 161 (6): 1456–1464. PMID 35202621. S2CID 247074537. doi:10.1016/j.chest.2022.02.025.
Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. August 2017, 390 (10095): 659–668. PMID 28687413. S2CID 4523731. doi:10.1016/S0140-6736(17)31281-3.
Popp M, Stegemann M, Riemer M, Metzendorf M, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Intervention Antibiotics for the treatment of COVID-19. Cochrane Database of Systematic Reviews. 22 October 2021, 10 (10): CD015025. PMC 8536098 . PMID 34679203. doi:10.1002/14651858.CD015025.
Nag K, Tripura K, Datta A, Karmakar N, Singh M, Singh M, Singal K, Pradhan P. Effect of Hydroxychloroquine and Azithromycin Combination Use in COVID-19 Patients - An Umbrella Review. Indian J Community Med //www.ncbi.nlm.nih.gov/pmc/articles/PMC10900474 |PMC=缺少标题 (帮助). 2024, 49 (1): 22–27. PMC 10900474 . PMID 38425958. doi:10.4103/ijcm.ijcm_983_22 .
Butler CC, Yu LM, Dorward J, Gbinigie O, Hayward G, Saville BR, Van Hecke O, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Djukanovic R, Gadola S, Kirkpatrick J, de Lusignan S, Ogburn E, Evans PH, Thomas NP, Patel MG, Hobbs FD. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. The Lancet. Respiratory Medicine. September 2021, 9 (9): 1010–1020. PMC 8315758 . PMID 34329624. doi:10.1016/S2213-2600(21)00310-6.
Platform trial rules out treatments for COVID-19. National Institute for Health and Care Research (NIHR). 31 May 2022 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于1 June 2022）.

drugs.com

Azithromycin International Brands. Drugs.com. [2017-02-27]. （原始内容存档于2017-02-28）.
Azithromycin Use During Pregnancy. Drugs.com. 2 May 2019 [2019-12-24]. （原始内容存档于2020-06-18）.
Azithromycin. The American Society of Health-System Pharmacists. [2015-08-01]. （原始内容存档于2015-09-05）.
Azithromycin use while Breastfeeding. [2015-09-01]. （原始内容存档于2015-09-05）.

europa.eu

ema.europa.eu

List of nationally authorised medicinal products Active substance: azithromycin (systemic use formulations) (PDF). European Medicine Agency. 2021-01-14 [2023-03-10]. （原始内容存档 (PDF)于2021-08-18）.

fda.gov

FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. U.S. Food and Drug Administration (FDA). 2013-03-12. （原始内容存档于2016-10-27）.

fkit.hr

pierre.fkit.hr

Banić Tomišić Z. The Story of Azithromycin. Kemija U Industriji. 2011, 60 (12): 603–617 [2013-04-15]. ISSN 0022-9830. （原始内容存档于2017-09-08）.

handle.net

hdl.handle.net

World Health Organization. The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.
World Health Organization. Critically important antimicrobials for human medicine 6th revision. Geneva: World Health Organization. 2018. ISBN 978-92-4-151552-8. hdl:10665/312266 . License: CC BY-NC-SA 3.0 IGO.

hanstenandhorn.com

John R. Horn; Philip D. Hansten. Life Threatening Colchicine Drug Interactions. Drug Interactions: Insights and Observations (PDF). 2006 [2024-01-16]. （原始内容存档 (PDF)于2023-11-23）.

harvard.edu

ui.adsabs.harvard.edu

Durán-Álvarez JC, Prado B, Zanella R, Rodríguez M, Díaz S. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment. Sci Total Environ. November 2023, 900: 165886. Bibcode:2023ScTEn.90065886D. PMID 37524191. S2CID 260323001. doi:10.1016/j.scitotenv.2023.165886.

medicaid.gov

data.medicaid.gov

National Average Drug Acquisition Cost (NADAC) Retrieved 24 May 2018.. Centers for Medicare and Medicaid Services. （原始内容存档于2018-05-24）.

medicines.org.uk

Zithromax Summary of Product Characteristics (SmPC). (emc). 2024-02-05 [2024-04-26].

msh.org

erc.msh.org

Azithromycin. International Drug Price Indicator Guide. [4 September 2015]. （原始内容存档于2020-03-24）.

nih.gov

ncbi.nlm.nih.gov

Dunker A, Kolanczyk DM, Maendel CM, Patel AR, Pettit NN. Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center. Hosp Pharm. November 2016, 51 (10): 830–833. PMC 5135431 . PMID 27928188. doi:10.1310/hpj5110-830.
Klapan I, Culig J, Oresković K, Matrapazovski M, Radosević S. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology. 1999, 20 (1): 7–11 [2024-05-31]. PMID 9950107. doi:10.1016/S0196-0709(99)90044-3. In adults with acute sinusitis, a 3-day course of azithromycin was as effective and well tolerated as a 10-day course of amoxicillin/clavulanic acid. A significantly simpler dosage regimen and faster clinical effect were the advantages of azithromycin.
Dawit G, Mequanent S, Makonnen E. Efficacy and safety of azithromycin and amoxicillin/clavulanate for otitis media in children: a systematic review and meta-analysis of randomized controlled trials. Annals of Clinical Microbiology and Antimicrobials. 2021, 20 (1): 28. PMC 8070272 . PMID 33894769. doi:10.1186/s12941-021-00434-x . Azithromycin is comparable to amoxicillin/clavulanate to treat otitis media in children, and it is safer and more tolerable.
Randel A. IDSA Updates Guideline for Managing Group A Streptococcal Pharyngitis. American Family Physician. September 2013, 88 (5): 338–40. PMID 24010402.
Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. The Cochrane Database of Systematic Reviews. November 2015, 11 (11): CD004008. PMC 4661324 . PMID 26568232. doi:10.1002/14651858.CD004008.pub3.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases //www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997 |PMC=缺少标题 (帮助). March 2007, 44 (Suppl 2): S27–72. PMC 7107997 . PMID 17278083. doi:10.1086/511159 .
Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. The Cochrane Database of Systematic Reviews. November 2015, 11 (11): CD004008. PMC 4661324 . PMID 26568232. doi:10.1002/14651858.CD004008.pub3.
Taylor SP, Sellers E, Taylor BT. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly. The American Journal of Medicine. December 2015, 128 (12): 1362.e1–6. PMID 26291905. doi:10.1016/j.amjmed.2015.07.032 .
Opitz DL, Harthan JS. Review of Azithromycin Ophthalmic 1% Solution (AzaSite) for the Treatment of Ocular Infections. Ophthalmol Eye Dis. 2012, 4: 1–14. PMC 3619494 . PMID 23650453. doi:10.4137/OED.S7791.
Amano A, Kishi N, Koyama H, Matsuzaki K, Matsumoto S, Uchino K, Yamaguchi H, Yokomizo A, Mizuno M. In vitro activity of sitafloxacin against atypical bacteria (2009-2014) and comparison between susceptibility of clinical isolates in 2009 and 2012. Jpn J Antibiot. September 2016, 69 (3): 131–142. PMID 30226949.
Simoens S, Laekeman G, Decramer M. Preventing COPD exacerbations with macrolides: a review and budget impact analysis. Respiratory Medicine. May 2013, 107 (5): 637–48. PMID 23352223. doi:10.1016/j.rmed.2012.12.019 .
Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. February 2004, 125 (2 Suppl): 52S–60S; quiz 60S–61S [2020-03-22]. PMID 14872001. doi:10.1378/chest.125.2_suppl.52S. （原始内容存档于2021-08-27）.
Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. European Journal of Clinical Pharmacology. May 2012, 68 (5): 479–503. PMID 22105373. S2CID 1904304. doi:10.1007/s00228-011-1161-x .
Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators of Inflammation //www.ncbi.nlm.nih.gov/pmc/articles/PMC3388425 |PMC=缺少标题 (帮助). 2012, 2012: 584262. PMC 3388425 . PMID 22778497. doi:10.1155/2012/584262 .
Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M, Novembre E. Azithromycin anaphylaxis in children. International Journal of Immunopathology and Pharmacology. 2014, 27 (1): 121–6. PMID 24674687. S2CID 45729751. doi:10.1177/039463201402700116 .
Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. The New England Journal of Medicine. May 2012, 366 (20): 1881–90. PMC 3374857 . PMID 22591294. doi:10.1056/NEJMoa1003833.
Tan MS, Gomez-Lumbreras A, Villa-Zapata L, Malone DC. Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure. Rheumatol Int. December 2022, 42 (12): 2253–2259. PMC 9473467 . PMID 36104598. doi:10.1007/s00296-022-05201-5.
Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review (PDF). Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317 [2024-02-02]. PMID 31628882. doi:10.1111/bcpt.13343. （原始内容存档 (PDF)于2024-02-02）.
Hicks LA, Taylor TH, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010. The New England Journal of Medicine. April 2013, 368 (15): 1461–2. PMID 23574140. doi:10.1056/NEJMc1212055 .
Hicks LA, Taylor TH, Hunkler RJ. More on U.S. outpatient antibiotic prescribing, 2010. The New England Journal of Medicine. September 2013, 369 (12): 1175–6. PMID 24047077. doi:10.1056/NEJMc1306863.
Durán-Álvarez JC, Prado B, Zanella R, Rodríguez M, Díaz S. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment. Sci Total Environ. November 2023, 900: 165886. Bibcode:2023ScTEn.90065886D. PMID 37524191. S2CID 260323001. doi:10.1016/j.scitotenv.2023.165886.
Southern KW, Barker PM. Azithromycin for cystic fibrosis. Eur Respir J. November 2004, 24 (5): 834–8. PMID 15516680. S2CID 17778741. doi:10.1183/09031936.04.00084304 .
Azithromycin and cystic fibrosis. Arch Dis Child. August 2022, 107 (8): 739. PMID 35853636. S2CID 250624603. doi:10.1136/archdischild-2022-324569.
Ghimire JJ, Jat KR, Sankar J, Lodha R, Iyer VK, Gautam H, Sood S, Kabra SK. Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial. Chest. June 2022, 161 (6): 1456–1464. PMID 35202621. S2CID 247074537. doi:10.1016/j.chest.2022.02.025.
Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. August 2017, 390 (10095): 659–668. PMID 28687413. S2CID 4523731. doi:10.1016/S0140-6736(17)31281-3.
Popp M, Stegemann M, Riemer M, Metzendorf M, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Intervention Antibiotics for the treatment of COVID-19. Cochrane Database of Systematic Reviews. 22 October 2021, 10 (10): CD015025. PMC 8536098 . PMID 34679203. doi:10.1002/14651858.CD015025.
Nag K, Tripura K, Datta A, Karmakar N, Singh M, Singh M, Singal K, Pradhan P. Effect of Hydroxychloroquine and Azithromycin Combination Use in COVID-19 Patients - An Umbrella Review. Indian J Community Med //www.ncbi.nlm.nih.gov/pmc/articles/PMC10900474 |PMC=缺少标题 (帮助). 2024, 49 (1): 22–27. PMC 10900474 . PMID 38425958. doi:10.4103/ijcm.ijcm_983_22 .
Butler CC, Yu LM, Dorward J, Gbinigie O, Hayward G, Saville BR, Van Hecke O, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Djukanovic R, Gadola S, Kirkpatrick J, de Lusignan S, Ogburn E, Evans PH, Thomas NP, Patel MG, Hobbs FD. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. The Lancet. Respiratory Medicine. September 2021, 9 (9): 1010–1020. PMC 8315758 . PMID 34329624. doi:10.1016/S2213-2600(21)00310-6.

dailymed.nlm.nih.gov

Zithromax- azithromycin dihydrate tablet, film coated; Zithromax- azithromycin dihydrate powder, for suspension. DailyMed. 2023-09-29 [2024-04-26].

pubmed.ncbi.nlm.nih.gov

Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. Postgrad Med. 2017-06, 129 (5): 493–499 [2024-10-04]. doi:10.1080/00325481.2017.1285677. （原始内容存档于2024-10-07）（英语）.

nihr.ac.uk

evidence.nihr.ac.uk

Platform trial rules out treatments for COVID-19. National Institute for Health and Care Research (NIHR). 31 May 2022 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于1 June 2022）.

nytimes.com

Grady D. Popular Antibiotic May Raise Risk of Sudden Death. The New York Times. 2012-05-16 [2012-05-18]. （原始内容存档于2012-05-17）.

researchgate.net

Banić Tomišić Z. The Story of Azithromycin. Kemija U Industriji: Časopis Kemičara I Kemijskih Inženjera Hrvatske. December 2011, 60 (12): 603–17 [2020-06-25]. （原始内容存档于2024-03-08）.

sciencedirect.com

Klapan I, Culig J, Oresković K, Matrapazovski M, Radosević S. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology. 1999, 20 (1): 7–11 [2024-05-31]. PMID 9950107. doi:10.1016/S0196-0709(99)90044-3. In adults with acute sinusitis, a 3-day course of azithromycin was as effective and well tolerated as a 10-day course of amoxicillin/clavulanic acid. A significantly simpler dosage regimen and faster clinical effect were the advantages of azithromycin.

sdu.dk

findresearcher.sdu.dk

Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review (PDF). Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317 [2024-02-02]. PMID 31628882. doi:10.1111/bcpt.13343. （原始内容存档 (PDF)于2024-02-02）.

semanticscholar.org

api.semanticscholar.org

Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. European Journal of Clinical Pharmacology. May 2012, 68 (5): 479–503. PMID 22105373. S2CID 1904304. doi:10.1007/s00228-011-1161-x .
Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M, Novembre E. Azithromycin anaphylaxis in children. International Journal of Immunopathology and Pharmacology. 2014, 27 (1): 121–6. PMID 24674687. S2CID 45729751. doi:10.1177/039463201402700116 .
Durán-Álvarez JC, Prado B, Zanella R, Rodríguez M, Díaz S. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment. Sci Total Environ. November 2023, 900: 165886. Bibcode:2023ScTEn.90065886D. PMID 37524191. S2CID 260323001. doi:10.1016/j.scitotenv.2023.165886.
Southern KW, Barker PM. Azithromycin for cystic fibrosis. Eur Respir J. November 2004, 24 (5): 834–8. PMID 15516680. S2CID 17778741. doi:10.1183/09031936.04.00084304 .
Azithromycin and cystic fibrosis. Arch Dis Child. August 2022, 107 (8): 739. PMID 35853636. S2CID 250624603. doi:10.1136/archdischild-2022-324569.
Ghimire JJ, Jat KR, Sankar J, Lodha R, Iyer VK, Gautam H, Sood S, Kabra SK. Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial. Chest. June 2022, 161 (6): 1456–1464. PMID 35202621. S2CID 247074537. doi:10.1016/j.chest.2022.02.025.
Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. August 2017, 390 (10095): 659–668. PMID 28687413. S2CID 4523731. doi:10.1016/S0140-6736(17)31281-3.

tga.gov.au

Zithromax azithromycin 500mg (as dihydrate) tablet blister pack (58797). Therapeutic Goods Administration (TGA). 2022-08-12 [2024-04-26].

web.archive.org

Azithromycin International Brands. Drugs.com. [2017-02-27]. （原始内容存档于2017-02-28）.
Azithromycin Use During Pregnancy. Drugs.com. 2 May 2019 [2019-12-24]. （原始内容存档于2020-06-18）.
List of nationally authorised medicinal products Active substance: azithromycin (systemic use formulations) (PDF). European Medicine Agency. 2021-01-14 [2023-03-10]. （原始内容存档 (PDF)于2021-08-18）.
Azithromycin. The American Society of Health-System Pharmacists. [2015-08-01]. （原始内容存档于2015-09-05）.
Azithromycin use while Breastfeeding. [2015-09-01]. （原始内容存档于2015-09-05）.
Azithromycin Stops The Growth of Bacteria. [2017-12-24]. （原始内容存档于2020-05-12）（德语）.
Greenwood D. Antimicrobial drugs : chronicle of a twentieth century medical triumph 1st. Oxford: Oxford University Press. 2008: 239. ISBN 978-0-19-953484-5. （原始内容存档于2016-03-05）.
Alapi EM, Fischer J. Table of Selected Analogue Classes. Fischer J, Ganellin CR (编). Analogue-based Drug Discovery. Weinheim: Wiley-Vch Verlag GmbH & Co. KGaA. 2006: 498 [2020-04-02]. ISBN 978-3-527-31257-3. （原始内容存档于2023-01-14）.
Azithromycin Stops The Growth of Bacteria. [2017-12-24]. （原始内容存档于2020-05-12）（德语）.
Tarascon pocket pharmacopoeia 2015 deluxe lab coat edition.. Jones & Bartlett Learning https://www.worldcat.org/oclc/922644939. 2014-01-01 [2016-12-16]. OCLC 922644939. （原始内容存档于2019-07-13）. 缺少或|title=为空 (帮助)
Azithromycin. International Drug Price Indicator Guide. [4 September 2015]. （原始内容存档于2020-03-24）.
National Average Drug Acquisition Cost (NADAC) Retrieved 24 May 2018.. Centers for Medicare and Medicaid Services. （原始内容存档于2018-05-24）.
Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. February 2004, 125 (2 Suppl): 52S–60S; quiz 60S–61S [2020-03-22]. PMID 14872001. doi:10.1378/chest.125.2_suppl.52S. （原始内容存档于2021-08-27）.
Grady D. Popular Antibiotic May Raise Risk of Sudden Death. The New York Times. 2012-05-16 [2012-05-18]. （原始内容存档于2012-05-17）.
FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. U.S. Food and Drug Administration (FDA). 2013-03-12. （原始内容存档于2016-10-27）.
John R. Horn; Philip D. Hansten. Life Threatening Colchicine Drug Interactions. Drug Interactions: Insights and Observations (PDF). 2006 [2024-01-16]. （原始内容存档 (PDF)于2023-11-23）.
Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review (PDF). Basic Clin Pharmacol Toxicol. April 2020, 126 (4): 307–317 [2024-02-02]. PMID 31628882. doi:10.1111/bcpt.13343. （原始内容存档 (PDF)于2024-02-02）.
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. Postgrad Med. 2017-06, 129 (5): 493–499 [2024-10-04]. doi:10.1080/00325481.2017.1285677. （原始内容存档于2024-10-07）（英语）.
Banić Tomišić Z. The Story of Azithromycin. Kemija U Industriji: Časopis Kemičara I Kemijskih Inženjera Hrvatske. December 2011, 60 (12): 603–17 [2020-06-25]. （原始内容存档于2024-03-08）.
Banić Tomišić Z. The Story of Azithromycin. Kemija U Industriji. 2011, 60 (12): 603–617 [2013-04-15]. ISSN 0022-9830. （原始内容存档于2017-09-08）.
Azithromycin: A world best-selling Antibiotic. www.wipo.int. World Intellectual Property Organization. [2019-06-18]. （原始内容存档于2020-12-06）.
Outpatient Antibiotic Prescriptions — United States, 2017 (PDF). U.S. Centers for Disease Control and Prevention (CDC). 2020-03-26 [2020-03-30]. （原始内容存档于2020-03-30）.
Outpatient Antibiotic Prescriptions — United States, 2022. U.S. Centers for Disease Control and Prevention (CDC). 2023-11-15 [2023-11-17]. （原始内容存档于2024-03-08）.
The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
Platform trial rules out treatments for COVID-19. National Institute for Health and Care Research (NIHR). 31 May 2022 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于1 June 2022）.

wipo.int

Azithromycin: A world best-selling Antibiotic. www.wipo.int. World Intellectual Property Organization. [2019-06-18]. （原始内容存档于2020-12-06）.

worldcat.org

Tarascon pocket pharmacopoeia 2015 deluxe lab coat edition.. Jones & Bartlett Learning https://www.worldcat.org/oclc/922644939. 2014-01-01 [2016-12-16]. OCLC 922644939. （原始内容存档于2019-07-13）. 缺少或|title=为空 (帮助)
Banić Tomišić Z. The Story of Azithromycin. Kemija U Industriji. 2011, 60 (12): 603–617 [2013-04-15]. ISSN 0022-9830. （原始内容存档于2017-09-08）.